The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis

References

• Hall MJ, Williams SN, DeFrances CJ, et al. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief. 2011;62:1–8.
   PubMedGoogle Scholar
• Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308–1316.
   PubMed Web of Science ®Google Scholar
• Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40:754–761.
   PubMed Web of Science ®Google Scholar
• Shen HN, Lu CL, Yang HH. Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006. Chest. 2010;138:298–304.
   PubMed Web of Science ®Google Scholar
• Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787–1794.
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NK, International Forum of Acute Care T, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259–272.
   PubMed Web of Science ®Google Scholar
• Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–851.
   PubMed Web of Science ®Google Scholar
• Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40:463–475.
   PubMed Web of Science ®Google Scholar
• Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5:4–11.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Leopold SJ, Cranendonk DR, et al. Host innate immune responses to sepsis. Virulence. 2014;5:36–44.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–810.
   PubMed Web of Science ®Google Scholar
• Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:775–787.
   PubMed Web of Science ®Google Scholar
• Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:762–774.
   PubMed Web of Science ®Google Scholar
• Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care. 2005;11:473–480.
   PubMed Web of Science ®Google Scholar
• Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med. 2008;29:591–603.
   PubMed Web of Science ®Google Scholar
• Andersen ES, Rodgaard-Hansen S, Moessner B, et al. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study. Eur J Clin Microbiol Infect Dis. 2014;33:117–122.
   PubMed Web of Science ®Google Scholar
• Kjaergaard AG, Rodgaard-Hansen S, Dige A, et al. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients. PLoS One. 2014;9:e92331.
   PubMed Web of Science ®Google Scholar
• Rodgaard-Hansen S, Rafique A, Christensen PA, et al. A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. CCLM/FESCC. 2014;52:453–461.
   PubMed Web of Science ®Google Scholar
• Rodgaard-Hansen S, Rafique A, Weis N, et al. Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival. Infect Diseases. 2015;47:203–208.
   PubMed Web of Science ®Google Scholar
• Laursen TL, Rodgaard-Hansen S, Moller HJ, et al. The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation. Liver Int. 2017;37:569–575.
   PubMed Web of Science ®Google Scholar
• Andersen MN, Andersen NF, Rodgaard-Hansen S, et al. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma. Leukemia Res. 2015;39:971–975.
   PubMed Web of Science ®Google Scholar
• Martinez-Pomares L. The mannose receptor. J Leukoc Biol . 2012;92:1177–1186.
   PubMed Web of Science ®Google Scholar
• Gazi U, Rosas M, Singh S, et al. Fungal recognition enhances mannose receptor shedding through dectin-1 engagement. J Biol Chem. 2011;286:7822–7829.
   PubMed Web of Science ®Google Scholar
• Salomao R, Brunialti MK, Rapozo MM, et al. Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock. 2012;38:227–242.
   PubMed Web of Science ®Google Scholar
• Martinez-Pomares L, Mahoney JA, Kaposzta R, et al. The murine mannose receptor is produced by macrophages in vitro and is present in mouse serum. J Biol Chem. 1998;273:23376–23380.
   PubMed Web of Science ®Google Scholar
• Jordens R, Thompson A, Amons R, et al. Human dendritic cells shed a functional, soluble form of the mannose receptor. Int Immunol. 1999;11:1775–1780.
   PubMed Web of Science ®Google Scholar
• Gaini S, Koldkjaer OG, Moller HJ, et al. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Crit Care. 2007;11:R76.
   PubMed Web of Science ®Google Scholar
• Gaini S, Koldkjaer OG, Pedersen C, et al. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care. 2006;10:R53.
   PubMed Web of Science ®Google Scholar
• Gaini S, Pedersen SS, Koldkaer OG, et al. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp Immunol. 2008;151:423–431.
   PubMed Web of Science ®Google Scholar